Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$795
in 4 filings, $795 under 10b5-1 plans

Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 39 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-06-26 Pomerantz Roger President and CEO Sale −21,224 $9.19 $195K 228,304
2018-06-26 Pomerantz Roger President and CEO Exercise or conversion · STOCK OPTION (RIGHT TO BUY) −21,224 873,929
2018-06-26 Kim Lorence H. Director Grant or award · Stock Option (right to buy) +15,000 15,000
2018-06-26 AFEYAN NOUBAR Director Grant or award · Stock Option (right to buy) +15,000 15,000
2018-06-26 Behar Gregory Director Grant or award · Stock Option (right to buy) +15,000 15,000
2018-06-26 Ausiello Dennis A Director Grant or award · Stock Option (right to buy) +15,000 15,000
2018-06-26 Graves Kurt Director Grant or award · Stock Option (right to buy) +15,000 15,000
2018-06-25 Pomerantz Roger President and CEO Exercise or conversion +16,288 $0.71 $12K 255,056
2018-06-25 Pomerantz Roger President and CEO Sale −26,752 $9.21 $247K 228,304
2018-06-25 Pomerantz Roger President and CEO Exercise or conversion · STOCK OPTION (RIGHT TO BUY) −16,288 895,153
2018-06-22 Pomerantz Roger President and CEO Sale −40,057 $9.36 $375K 238,768
2018-06-21 Pomerantz Roger President and CEO Sale −18,987 $9.06 $172K 278,825
2018-06-20 Pomerantz Roger President and CEO Sale −26,492 $9.33 $247K 297,812
2018-06-19 Aunins John G. Chief Technology Officer & EVP Exercise or conversion +5,000 175,206
2018-06-19 Aunins John G. Chief Technology Officer & EVP Exercise or conversion · RESTRICTED STOCK UNITS −5,000 10,000
2018-06-15 Aunins John G. Chief Technology Officer & EVP Sale −14,279 $8.57 $122K 170,206
2018-05-15 Aunins John G. Sale −14,279 $8.08 $115K 146,648
2018-05-09 Pomerantz Roger President and CEO Sale −233 $9.00 $2K 324,304
2018-04-25 Aunins John G. Chief Technology Officer & EVP Sale −14,279 $7.58 $108K 184,485
2018-01-30 Pomerantz Roger President and CEO Grant or award · Stock Option (right to buy) −278,000 278,000

Page 28 of 34 · 662 trades